Science Explorer Back to mapMap
Discussion

Adamas Pharmaceuticals (United States)

Research works
108
▼ 13% vs 2018-21
Citations
11k
105.9 per fractional work
Top-10% rate
11.7%
all institutions 10.0%
Open access
30%
world 40%
International
23%
world 18%

Not ranked overall: Adamas Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Adamas Pharmaceuticals (United States) work in?

In all years, 41% of research at Adamas Pharmaceuticals (United States) is in Life Sciences, 36% in Health Sciences. Its largest fields are Medicine (34%), Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (7%). It does 2.5× the world's share of Life Sciences.

Life Sciences: 45 fractional works · 41.4% of its workBiochemistry, Genetics and Molecular Biology: 33 fractional works · 30.5% of its workMolecular Biology: 24 fractional works · 22.6% of its workGenetics: 3 fractional works · 2.8% of its workCancer Research: 1 fractional works · 1.3% of its workCell Biology: 1 fractional works · 1.3% of its workBiotechnology: 1 fractional works · 0.8% of its workBiophysics: 1 fractional works · 0.6% of its workBiochemistry: 1 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 8 fractional works · 7.0% of its workImmunology: 5 fractional works · 4.6% of its workVirology: 2 fractional works · 1.7% of its workMicrobiology: 1 fractional works · 0.7% of its workNeuroscience: 2 fractional works · 1.6% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.1% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 1.4% of its workPharmacology: 1 fractional works · 1.0% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.9% of its workAgronomy and Crop Science: 0 fractional works · 0.3% of its workPlant Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Sciences: 39 fractional works · 36.4% of its workMedicine: 37 fractional works · 34.2% of its workEpidemiology: 6 fractional works · 5.3% of its workNeurology: 6 fractional works · 5.1% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 4.2% of its workOncology: 4 fractional works · 3.8% of its workHepatology: 2 fractional works · 1.6% of its workPsychiatry and Mental health: 2 fractional works · 1.5% of its workPediatrics, Perinatology and Child Health: 2 fractional works · 1.4% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.4% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.3% of its workPhysiology: 1 fractional works · 1.3% of its workSurgery: 1 fractional works · 1.3% of its workInfectious Diseases: 1 fractional works · 1.1% of its workGenetics: 1 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.6% of its workPharmacology: 1 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workRheumatology: 0 fractional works · 0.3% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.3% of its workHematology: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 1.0% of its workHealth Professions: 2 fractional works · 1.6% of its workGeneral Health Professions: 1 fractional works · 0.6% of its workEmergency Medical Services: 0 fractional works · 0.5% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workPhysical Sciences: 16 fractional works · 15.3% of its workEnvironmental Science: 4 fractional works · 4.0% of its workEcology: 2 fractional works · 1.6% of its workEnvironmental Engineering: 1 fractional works · 0.7% of its workPollution: 1 fractional works · 0.6% of its workGlobal and Planetary Change: 0 fractional works · 0.3% of its workEnvironmental Chemistry: 0 fractional works · 0.3% of its workWater Science and Technology: 0 fractional works · 0.3% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.2% of its workEngineering: 4 fractional works · 3.9% of its workBiomedical Engineering: 1 fractional works · 1.1% of its workCivil and Structural Engineering: 1 fractional works · 1.0% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workControl and Systems Engineering: 0 fractional works · 0.3% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.3% of its workAerospace Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.5% of its workChemistry: 2 fractional works · 2.2% of its workOrganic Chemistry: 2 fractional works · 1.8% of its workSpectroscopy: 0 fractional works · 0.4% of its workMaterials Science: 2 fractional works · 2.2% of its workPolymers and Plastics: 1 fractional works · 0.9% of its workMaterials Chemistry: 1 fractional works · 0.9% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 1 fractional works · 0.9% of its workComputational Theory and Mathematics: 1 fractional works · 0.6% of its workSignal Processing: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnergy: 1 fractional works · 0.9% of its workRenewable Energy, Sustainability and the Environment: 1 fractional works · 0.9% of its workEarth and Planetary Sciences: 1 fractional works · 0.7% of its workGeophysics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workSocial Sciences: 7 fractional works · 6.9% of its workArts and Humanities: 2 fractional works · 2.1% of its workLanguage and Linguistics: 1 fractional works · 0.8% of its workHistory and Philosophy of Science: 1 fractional works · 0.6% of its workHistory: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workSocial Sciences: 2 fractional works · 1.5% of its workPolitical Science and International Relations: 1 fractional works · 0.7% of its workAnthropology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 2 fractional works · 1.4% of its workEconomics and Econometrics: 2 fractional works · 1.4% of its workPsychology: 1 fractional works · 0.9% of its workClinical Psychology: 1 fractional works · 0.5% of its workApplied Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 1 fractional works · 0.7% of its workManagement Science and Operations Research: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.3% of its workALL ITS WORKAdamasPharmaceuticals…108fractional works, all years
Life Sciences41%Physical Sciences15%Health Sciences36%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 24 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3330.5%
    2. Immunology and Microbiology87.0%
    3. Neuroscience21.6%
    4. Pharmacology, Toxicology and Pharmaceutics21.4%
    5. Agricultural and Biological Sciences10.9%
    1. Medicine3734.2%
    2. Health Professions21.6%
    3. Nursing00.4%
    4. Veterinary00.2%
    1. Environmental Science44.0%
    2. Engineering43.9%
    3. Chemistry22.2%
    4. Materials Science22.2%
    5. Computer Science10.9%
    6. Energy10.9%
    7. Earth and Planetary Sciences10.7%
    8. Mathematics00.4%
    9. Physics and Astronomy00.2%
    1. Arts and Humanities22.1%
    2. Social Sciences21.5%
    3. Economics, Econometrics and Finance21.4%
    4. Psychology10.9%
    5. Decision Sciences10.7%
    6. Business, Management and Accounting00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.64× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 0.94× its world share, 0 worksImmunology and Micro…Neuroscience: 0.37× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.36× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.08× its world share, 0 worksChemistryEarth and Planetary Sciences: 0.87× its world share, 0 worksEarth and Planetary …Engineering: 0.28× its world share, 0 worksEngineeringEnvironmental Science: 2.74× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.54× its world share, 0 worksMaterials ScienceMathematics: 0.80× its world share, 0 worksMathematicsHealth Professions: 0.24× its world share, 0 worksHealth ProfessionsMedicine: 2.50× its world share, 4 worksMedicineEconomics, Econometrics and Finance: 0.44× its world share, 0 worksEconomics, Econometr…Psychology: 1.24× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.4×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics5.36×0 works
  2. Biochemistry, Genetics and Molecular Biology3.64×2 works
  3. Environmental Science2.74×1 works
  4. Medicine2.50×4 works
  5. Psychology1.24×0 works
  6. Chemistry1.08×0 works
  7. Immunology and Microbiology0.94×0 works
  8. Earth and Planetary Sciences0.87×0 works
  9. Mathematics0.80×0 works
  10. Materials Science0.54×0 works
  11. Economics, Econometrics and Finance0.44×0 works
  12. Neuroscience0.37×0 works
  13. Engineering0.28×0 works
  14. Health Professions0.24×0 works

Who are the top researchers at Adamas Pharmaceuticals (United States)?

Ranked on the quality score, Jack T Nguyen, Gregory T. Went and Rajiv Patni lead among researchers whose main affiliation is Adamas Pharmaceuticals (United States).

  1. 1 Jack T Nguyen United States · #335,829 worldwide 6.1k citations · 71 works
  2. 2 Gregory T. Went United States · #425,879 worldwide 2.6k citations · 29 works
  3. 3 Rajiv Patni United States · #3,519,143 worldwide 723 citations · 30 works
  4. 4 Reed Johnson United States · #3,605,993 worldwide 494 citations · 18 works
All ranked researchers at Adamas Pharmaceuticals (United States)

What are the most cited papers from Adamas Pharmaceuticals (United States)?

The most cited paper from Adamas Pharmaceuticals (United States) is "Loss of PTEN facilitates HIF-1-mediated gene expression" (WAYNE S. ZUNDEL, Cornelia Schindler, Daphne Adele Haas-Kogan et al., 2000), with 836 citations. Next come "Requirements for high impact diagnostics in the developing world" (604) and "Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality." (601).

Most cited papers
#PaperReleasedCitations
1 Loss of PTEN facilitates HIF-1-mediated gene expression WAYNE S. ZUNDEL, Cornelia Schindler, Daphne Adele Haas-Kogan et al. · Genes & Development Open access 15 Feb 2000 836
2 Requirements for high impact diagnostics in the developing world Mickey S. Urdea, Laura Penny, Stuart S. Olmsted et al. · Nature Nov 2006 604
3 Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Laurie Stephens, Ann E. Sutherland, Irina V. Klimanskaya et al. · Genes & Development Open access Aug 1995 601
4 Detection of Human Papillomavirus DNA in Cytologically Normal Women and Subsequent Cervical Squamous Intraepithelial Lesions Kao‐Lee Liaw, A. G. Glass, M. Michele Manos et al. · JNCI Journal of the National Cancer Institute 2 Jun 1999 251
5 HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1 Kenji Uchimura, Megumi Morimoto‐Tomita, Annette Bistrup et al. · BMC Biochemistry Open access 17 Jan 2006 220
All 60 most cited papers, with filters and sorting

Which keywords describe research at Adamas Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Immune Response, Cancer, Glycosylation, Cancer Therapy, Monoclonal Antibodies, Inflammation, Antiviral Therapy and Epidemiology.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology8▲ 1.79×27 topics
  2. Cancer7▲ 4.9×17 topics
  3. Inflammation6▲ 2.6×22 topics
  4. Immune Response6▲ 9.5×9 topics
  5. Glycosylation6▲ 23×3 topics
  6. Cancer Therapy5▲ 7.4×8 topics
  7. Oxidative Stress5▲ 2.5×15 topics
  8. Monoclonal Antibodies4▲ 25×3 topics
  9. Antiviral Therapy4▲ 23×3 topics
  10. Genomics3▲ 8.9×4 topics
  11. Parkinson's Disease3▲ 14×6 topics
  12. Therapeutic Antibodies3▲ 24×2 topics
  13. Vaccine3▲ 7.5×6 topics
  14. Antibodies3▲ 33×2 topics
  15. Gene Therapy3▲ 11×3 topics
  16. Gene Expression3▲ 4.6×6 topics
  17. Liver Disease3▲ 20×2 topics
  18. Neurodegeneration3▲ 8.8×7 topics
  19. Transcriptional Regulation3▲ 11×6 topics
  20. Drug Discovery3▲ 6.5×4 topics
  21. Virus3▲ 21×2 topics
  22. Antibody Engineering3▲ 24×1 topic
  23. Apoptosis3▲ 6.2×3 topics
  24. Fc Receptors3▲ 24×1 topic
  25. Angiogenesis2▲ 5.7×9 topics
  26. Antiretroviral Therapy2▲ 10×3 topics
  27. Pharmacology2▲ 7.0×5 topics
  28. Genomic Integration2▲ 21×2 topics
  29. Mitochondrial Dysfunction2▲ 6.2×6 topics
  30. Therapeutics2▲ 16×2 topics
  31. Cell Signaling2▲ 6.4×6 topics
  32. Glycans2▲ 26×1 topic
  33. Immune System2▲ 6.5×1 topic
  34. Ribosome2▲ 22×1 topic
  35. Translation2▲ 10×1 topic
  36. Therapy2▲ 9.7×3 topics
  37. Calcium Signaling2▲ 15×2 topics
  38. Quantitative2▲ 16×2 topics
  39. Cell Migration2▲ 21×2 topics
  40. HIV2▲ 15×2 topics

Which research topics does Adamas Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Pediatric Pain Management Techniques, Digital Mental Health Interventions and Telemedicine and Telehealth Implementation.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  2. 2 Pediatric Pain Management Techniques Pediatrics, Perinatology and Child Health 0 works
  3. 3 Digital Mental Health Interventions Applied Psychology 0 works
  4. 4 Telemedicine and Telehealth Implementation Public Health, Environmental and Occupational Health 0 works
  5. 5 Hydrology and Watershed Management Studies Water Science and Technology 0 works
  6. 6 Flood Risk Assessment and Management Global and Planetary Change 0 works
  7. 7 Chronic Lymphocytic Leukemia Research Genetics 0 works
  8. 8 Pharmacovigilance and Adverse Drug Reactions Toxicology 0 works
  9. 9 Schizophrenia research and treatment Psychiatry and Mental health 0 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.9%not open70.1%

World: 40% of research is openly available.

with international co-authors22.7%domestic only77.3%

World: 18% is written across borders.

How has Adamas Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 13% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Adamas Pharmaceuticals (United States) as a percentage of every work published that year, 0.000032% in 2024.

still counting0.00050%0.0010%Adamas Pharmaceuticals (United States)0.000066% in 202519801990200020102020

Fractional works of Adamas Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Emeryville

All research institutions in Emeryville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Adamas Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.